Business Context and Reporting Period
This Form 8-K Current Report is filed by Community Health Systems, Inc. (NYSE: CYH) on December 10, 2025. The filing reports significant changes in executive leadership and board composition effective immediately on the date of the report.
Key Financial Metrics
The filing text does not provide specific financial data, including revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on corporate governance and personnel appointments.
Material Changes
The following executive appointments and board changes were announced:
- Kevin J. Hammons (age 60) was appointed Chief Executive Officer and Member of the Board of Directors, effective immediately. He previously served as President and Interim CEO. His director term expires at the 2026 Annual Meeting of Stockholders. He will not receive additional compensation for his board service.
- Jason K. Johnson (age 51) was appointed Executive Vice President and Chief Financial Officer, effective immediately. He previously served as Senior Vice President, Chief Accounting Officer, and Interim CFO.
- Phillip A. Posey (age 41) was appointed Senior Vice President and Chief Accounting Officer, effective January 1, 2026. He will replace Mr. Johnson in the Chief Accounting Officer role. Mr. Posey will serve as the principal accounting officer responsible for SEC reporting and financial statement audits.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook statements, or specific risk factors. Management commentary is limited to the biographical details of the new appointees and the confirmation that no new material plans, contracts, or arrangements were entered into in connection with these specific appointments.
Investor Verification Checklist
- Verify the transition timeline for the Chief Accounting Officer role between Jason K. Johnson and Phillip A. Posey (effective Jan 1, 2026).
- Review the prior Form 8-K filed on July 23, 2025, for full biographical details on Kevin J. Hammons and Jason K. Johnson.
- Confirm the absence of new compensation agreements or severance plans associated with these appointments as stated in the filing.
- Monitor the upcoming 2026 Annual Meeting of Stockholders regarding Mr. Hammons' director term expiration.